CeriBell Inc reports results for the quarter ended March 31 - Earnings Summary

• CeriBell Inc CBLL.OQ reported a quarterly adjusted loss of 40 cents​​ per share for the quarter ended March 31. The mean expectation of six analysts for the quarter was for a loss of 42 cents per share. Wall Street expected results to range from -49 cents to -34 cents per share.

• Revenue was $18.53 million​; analysts expected $19.25 million.

• CeriBell Inc's reported EPS for the quarter was a loss of 40 cents​.

• The company reported a quarterly loss of $12.58 million.

• CeriBell Inc shares had fallen by 16.7% this quarter and lost 38.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 32.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for CeriBell Inc is $32.00

This summary was machine generated from LSEG data May 8 at 09:55 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)